SCHEMBL18267906

SCHEMBL18267906

Cc1ccc2c(c1)C(C)(C)c1cc(-c3ccccc3)ccc1N2c1ccc(-c2ccccc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 2/20 0.38
FAAH O00519 1/20 0.37
MGLL Q99685 1/20 0.37
APP P05067 1/20 0.36
KDM4E B2RXH2 4/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
MAPT P10636 3/20 0.36
FLT3 P36888 1/20 0.36
HTT P42858 1/20 0.36
ADAMTS5 Q9UNA0 2/20 0.36
PDK2 Q15119 1/20 0.34
ALDH1A1 P00352 3/20 0.33
EGLN1 Q9GZT9 2/20 0.33
HSD17B10 Q99714 1/20 0.33
HPGD P15428 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
SLC2A1 P11166 1/20 0.33
ALDH1A3 P47895 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16773718 0.94 PGR (0.40) PGRFAAHMGLLAPPKDM4E
SCHEMBL13557666 0.94 ALDH1A1 (0.38) PGRKDM4EMEN1KMT2AMAPT
SCHEMBL15464027 0.92 FAAH (0.42) PGRFAAHMGLLAPPHTT
SCHEMBL13557634 0.92 FAAH (0.42) PGRFAAHMGLLAPPHTT
SCHEMBL15463966 0.92 FAAH (0.42) PGRFAAHMGLLAPPHTT
SCHEMBL13557633 0.92 FAAH (0.42) PGRFAAHMGLLAPPHTT
SCHEMBL15469328 0.92 FAAH (0.42) PGRFAAHMGLLAPPHTT
SCHEMBL13827535 0.91 FAAH (0.39) PGRFAAHMGLLKMT2AADAMTS5
SCHEMBL13557548 0.91 FAAH (0.39) PGRFAAHMGLLKMT2AADAMTS5
SCHEMBL13557642 0.91 FAAH (0.39) PGRFAAHMGLLKMT2AADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10297759-B2 Compound and organic electroluminescent device comprising same DOOSAN CORPORATION (KR) 2019-05-21 US disclosed
US-10008675-B2 Organic compound and organic electroluminescent element comprising same DOOSAN CORPORATION (KR) 2018-06-26 US disclosed
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME DOOSAN CORPORATION (KR) 2016-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10297759-B2 Compound and organic electroluminescent device comprising same TMEM109, L1CAM, OR10J3 PGR 2067/4885FAAH 3066/4885MGLL 332/4885
US-20160351825-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME OR10J3, ORAI2, ETV6 PGR 2741/4885FAAH 4178/4885MGLL 877/4885
US-10008675-B2 Organic compound and organic electroluminescent element comprising same OR10J3, ORAI2, ETV6 PGR 2741/4885FAAH 4178/4885MGLL 877/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.